Eli Samaha - 07 Aug 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Reporting relationship: 10%+ Owner
Issuer ticker: TBPH
Reported as of: 07 Aug 2024
Net transaction value: +$7,798,440
SEC form: 4
Accepted by SEC: 09 Aug 2024, 18:02:35 UTC
Prior SEC filing: 03 Jul 2024
Next SEC filing: 03 Oct 2024
Source filing: View source filing
Reporting owner signature: Eli Samaha

Key filing fact

Eli Samaha filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 09 Aug 2024.

Key facts

This page summarizes Eli Samaha's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Aug 2024, 18:02.

Change

Previous filing in this sequence was filed on 03 Jul 2024.
Current net transaction value: +$7,798,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBPH transaction

COM

Purchase

Transaction value: $7,798,440
Shares: +999,800
Change %: +12%
Price: $7.80
Shares after: 9,511,150
Date: 07 Aug 2024
Ownership: See Footnotes
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.